Journal Articles- Refereed

Berghuis AMS, Koffijberg H, Prakash J, Terstappen LWMM, IJzerman MJ. Detecting Blood-Based Biomarkers in Metastatic Breast Cancer: A Systematic Review of Their Current Status and Clinical Utility. Int J Mol Sci. Multidisciplinary Digital Publishing Institute; 2017 Feb 9;18(2):363.

Brinkhof S, Groen HJM, Siesling SS, IJzerman MJ. Resource utilization in lung cancer diagnostic procedures: Current use and budget consequences. PLoS ONE. 2017 Dec 7;12(12):e0189251–7.

Broekhuizen H, Groothuis-Oudshoorn CGM, Vliegenthart R, Groen H, IJzerman MJ. Public Preferences for Lung Cancer Screening Policies. Value Health. 2017 Aug;20(7):961–8.

Crown W, Buyukkaramikli N, Thokala P, Morton A, Sir MY, Marshall DA, IJzerman MJ et al. Constrained Optimization Methods in Health Services Research-An Introduction: Report 1 of the ISPOR Optimization Methods Emerging Good Practices Task Force. Value Health. 2017 Mar;20(3):310–9.

Degeling K, IJzerman MJ, Koopman M, Koffijberg H. Accounting for parameter uncertainty in the definition of parametric distributions used to describe individual patient variation in health economic models. BMC Med Res Methodol; 2017 Dec 15;17(1):170–12.

Degeling K, Koffijberg H, IJzerman MJ. A systematic review and checklist presenting the main challenges for health economic modeling in personalized medicine: towards implementing patient-level models. Expert Rev Pharmacoecon Outcomes Res. Taylor & Francis; 2017 Feb;17(1):17–25.

Degeling K, Schivo S, Mehra N, Koffijberg H, Langerak R, de Bono JS, IJzerman MJ. Comparison of Timed Automata with Discrete Event Simulation for Modeling of Biomarker-Based Treatment Decisions: An Illustration for Metastatic Castration-Resistant Prostate Cancer. Value in Health. 2017 Jul;in press(10):1411–9.

Mewes JC, Steuten LMG, IJzerman MJ, van Harten WH. A systematic approach for assessing, in the absence of full evidence, whether multicomponent interventions can be more cost-effective than single component interventions. Int J Technol Assess Health Care. 2017 Sep 11;:1–10.

Mewes JC, Steuten LMG, IJsbrandy C, IJzerman MJ, van Harten WH. Value of Implementation of Strategies to Increase the Adherence of Health Professionals and Cancer Survivors to Guideline-Based Physical Exercise. Value in Health. 2017 Jun.

Otten JWM, Witteveen A, Vliegen IMH, Siesling S, Timmer JB, IJzerman MJ. Stratified Breast Cancer Follow-Up Using a Partially Observable MDP. In: Markov Decision Processes in Practice. Cham: Springer, Cham; 2017. pp. 223–44. (International Series in Operations Research & Management Science; vol. 248).

van Harten W, IJzerman MJ. Responsible pricing in value-based assessment of cancer drugs: real-world data are an inevitable addition to select meaningful new cancer treatments. Ecancermedicalscience. 2017;11:ed71.